Citigroup Inc Biomarin Pharmaceutical Inc Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Citigroup Inc holds 169,683 shares of BMRN stock, worth $12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

169,683

Previous 222,374 23.69%

Holding current value

$12 Million

Previous $19.4 Million 28.07%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $3.92 Million - $4.86 Million	-52,691 Reduced 23.69%	169,683 $14 Million
Q1 2024 May 10, 2024	BUY	$83.81 - $99.0 $2.65 Million - $3.13 Million	31,582 Added 16.55%	222,374 $19.4 Million
Q4 2023 Feb 09, 2024	SELL	$76.22 - $98.51 $1.4 Million - $1.8 Million	-18,316 Reduced 8.76%	190,792 $18.4 Million
Q3 2023 Nov 09, 2023	SELL	$85.07 - $94.48 $658,952 - $731,842	-7,746 Reduced 3.57%	209,108 $18.5 Million
Q2 2023 Aug 10, 2023	SELL	$86.68 - $100.3 $4.57 Million - $5.29 Million	-52,752 Reduced 19.57%	216,854 $18.8 Million
Q1 2023 May 11, 2023	BUY	$87.74 - $117.27 $7.96 Million - $10.6 Million	90,762 Added 50.75%	269,606 $26.2 Million
Q4 2022 Feb 09, 2023	SELL	$80.93 - $108.63 $2.68 Million - $3.6 Million	-33,171 Reduced 15.65%	178,844 $18.5 Million
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $2.68 Million - $3.16 Million	32,579 Added 18.16%	212,015 $18 Million
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $4.17 Million - $5.06 Million	58,316 Added 48.15%	179,436 $14.9 Million
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $14.4 Million - $18 Million	-194,424 Reduced 61.62%	121,120 $9.34 Million
Q4 2021 Feb 10, 2022	BUY	$71.72 - $91.47 $5.47 Million - $6.98 Million	76,314 Added 31.9%	315,544 $27.9 Million
Q3 2021 Nov 10, 2021	BUY	$74.77 - $85.47 $17.9 Million - $20.4 Million	239,230 New	239,230 $18.5 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account